recent fda approval of exa-cel & lovo-cel for patients with scd
Published 7 months ago • 568 plays • Length 1:25Download video MP4
Download video MP3
Similar videos
-
1:43
approval of exa-cel for scd
-
0:36
the recent expanded fda approval of cilta-cel and ide-cel into earlier lines of myeloma treatment
-
0:44
the recent fda approval of ponatinib for ph all following success in the phallcon trial
-
1:10
upcoming novel agents for the treatment of sickle cell disease
-
3:34
transcend-cll-004: pivotal in the fda approval of liso-cel for r/r cll
-
1:36
the limitations and future of precision medicine in sickle cell disease
-
9:21
dkms life science lab: what happens after you swab?
-
5:05
hope for a cure: treating sickle cell disease with crispr
-
10:33
interdisciplinary rounds
-
4:45
safety and efficacy of obe-cel in r/r adult b-all: results of the pivotal felix study
-
1:25
the use of clonoseq to monitor mrd in patients with lbcl treated with axi-cel in zuma-7
-
1:53
sickle cell disease: an overview and future therapies
-
3:33
a novel composite endpoint of toxicity and pfs in patients with r/r fl treated with axi-cel
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
1:17
novel biomarkers and emerging therapies for sickle cell disease
-
3:03
outcomes following venetoclax monotherapy in patients with r/r wm in the real-world setting
-
1:43
the role of complement activation in complications of sickle cell disease
-
2:23
improved clinician-reported outcomes with voxelotor in patients with scd: phase iii hope trial
-
1:11
precision medicine in sickle cell disease: current status and future outlooks
-
4:43
novel treatments being explored for patients with hemophilia: highlights from isth 2024
-
3:10
phase ii study of all-oral aaa regimen for patients with newly diagnosed apl
-
6:57
hope for sickle cell: promising data for voxelotor